Renal cell carcinoma

Common Name(s)

Renal cell carcinoma

Renal cell carcinoma (RCC) is one of the most common types of kidney cancers seen in adults. RCC occurs more often in men between the ages of 50 to 70. The kidneys help get rid of waste in the body. There are small tubes in the kidneys that help filter waste from the blood and help make urine. RCC occurs when cells start growing uncontrollably in the lining of these small tubes. Symptoms may not appear in the early stages of renal cell carcinoma, which is why renal cell carcinoma is normally advanced when found. Later symptoms may include blood in urine, a lump in the abdomen, weight loss, anemia, and loss of appetite. If untreated, it may spread to the lymph nodes, lungs, liver, adrenal glands, brain, or bones.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Renal cell carcinoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Renal cell carcinoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Renal cell carcinoma" returned 2770 free, full-text research articles on human participants. First 3 results:

Mast cell density, microvessel density and their role in renal cell carcinoma.
 

Author(s): Öner Özdemir

Journal: J Pak Med Assoc. 2014 Dec;64(12):1433.

 

Last Updated: 6 Apr 2015

Go To URL
IL8 polymorphisms and overall survival in pazopanib- or sunitinib-treated patients with renal cell carcinoma.
 

Author(s): C-F Xu, T Johnson, J Garcia-Donas, T K Choueiri, C N Sternberg, I D Davis, N Bing, K C Deen, Z Xue, L McCann, E Esteban, J C Whittaker, C F Spraggs, C Rodríguez-Antona, L N Pandite, R J Motzer

Journal:

 

We evaluated germline single nucleotide polymorphisms (SNPs) for association with overall survival (OS) in pazopanib- or sunitinib-treated patients with advanced renal cell carcinoma (aRCC).

Last Updated: 1 Apr 2015

Go To URL
Activity and safety of sunitinib in poor risk metastatic renal cell carcinoma patients.
 

Author(s): Romualdo Barroso-Sousa, Rodrigo R Munhoz, Milena P Mak, Leonardo G Fonseca, Angelo B S Fede, Rudinei Diogo Marques Linck, Clovis R Coelho, Camila M V Moniz, Ciro E Souza, Carlos Dzik

Journal: Int Braz J Urol. ;40(6):835-41.

 

To assess the activity, safety and treatment patterns of sunitinib in patients with poor-risk metastatic renal cell carcinoma (mRCC).

Last Updated: 24 Jan 2015

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Renal cell carcinoma" returned 291 free, full-text review articles on human participants. First 3 results:

Renal cell carcinoma.
 

Author(s): Eric Jonasch, Jianjun Gao, W Kimryn Rathmell

Journal:

 

The treatment of renal cell carcinoma (RCC) has changed greatly over the past 15 years. Progress in the surgical management of the primary tumor and increased understanding of the molecular biology and genomics of the disease have led to the development of new therapeutic agents. ...

Last Updated: 11 Nov 2014

Go To URL
Risk of chronic kidney disease after nephrectomy for renal cell carcinoma.
 

Author(s): Seung-Kwon Choi, Cheryn Song

Journal: Korean J Urol. 2014 Oct;55(10):636-42.

 

The incidence of low-stage renal cell carcinoma is rising and is observed to demonstrate excellent prognosis following surgical treatment irrespective of method. However, several epidemiologic observational and population-based studies suggest that radical nephrectomy is associated ...

Last Updated: 17 Oct 2014

Go To URL
Robotic radical nephrectomy for renal cell carcinoma: a systematic review.
 

Author(s): Anastasios D Asimakopoulos, Roberto Miano, Filippo Annino, Salvatore Micali, Enrico Spera, Beniamino Iorio, Giuseppe Vespasiani, Richard Gaston

Journal:

 

Laparoscopic radical nephrectomy (LRN) is the actual gold-standard for the treatment of clinically localized renal cell carcinoma (RCC) (cT1-2 with no indications for nephron-sparing surgery). Limited evidence is currently available on the role of robotics in the field of radical ...

Last Updated: 24 Sep 2014

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)
 

Status: Recruiting

Condition Summary: Advanced Renal Cell Carcinoma; Renal Cell Carcinoma; Metastatic Renal Cell Carcinoma

 

Last Updated: 15 May 2015

Go to URL
Immunotherapy Study for Metastatic Renal Cell Cancer
 

Status: Recruiting

Condition Summary: Metastatic Renal Cell Carcinoma; Metastatic Clear-cell Renal Cancer; Recurrent Renal Cell Carcinoma; Refractory Renal Cell Carcinoma; Metastatic Kidney Cancer

 

Last Updated: 17 Jun 2015

Go to URL
A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma
 

Status: Recruiting

Condition Summary: ccRCC; RCC; Kidney Cancer; Clear Cell Renal Cell Carcinoma; Renal Cell Carcinoma

 

Last Updated: 20 Apr 2015

Go to URL